Random blood glucose and subsequent autoimmune hepatitis in the UK Biobank cohort

Background The association between baseline random blood glucose (RBG) and subsequent autoimmune hepatitis (AIH), and its relationship with systemic inflammation, remain unclear. Method The original UK Biobank analysis included 425,489 participants with 284 AIH records. After exclusion of two participants with AIH recorded on or before baseline, the prospective analyses included 425,487 participants and 282 incident hospital-recorded AIH events. A small hospital-based case-control sample from the Affiliated Hospital of Qingdao University, comprising 23 AIH cases and nine controls, provided supplementary descriptive information and exploratory analyses and was not used for external validation. Logistic regression, Cox regression, and two-year landmark analyses were used to examine the associations with AIH. Restricted cubic spline, exploratory threshold, subgroup, ROC, and mediation analyses were also performed. The jointly adjusted Cox model included age, sex, ethnicity, Townsend deprivation index, educational attainment, smoking status, and alcohol consumption. Result In the jointly adjusted baseline Cox model, each 1 mmol/L higher RBG was associated with an HR of 1.096 (95% CI, 1.023-1.176; P = 0.0095), whereas the highest-versus-lowest quartile comparison was not statistically significant (HR, 1.315; 95% CI, 0.945-1.831; P = 0.1046). In the two-year landmark analysis, the corresponding HRs were 1.115 (95% CI, 1.042-1.193; P = 0.0016) and 1.549 (95% CI, 1.080-2.222; P = 0.0175). RBG alone showed limited discrimination (AUC, 0.531; 95% CI, 0.496-0.566). Conclusion Higher baseline RBG was modestly associated with subsequent hospital-recorded AIH, although quartile comparisons differed between baseline and landmark analyses. These exploratory findings do not establish causality or a clinically actionable glucose threshold. The limited discrimination of RBG does not support its use as a standalone screening marker for AIH.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.1938930
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Random blood glucose and subsequent autoimmune hepatitis in the UK Biobank cohort

Tingfei Yan, Xiaobei Han, Xuedi Cheng, Junzheng Wang et al.
1 links
Frontiers in Immunology
Liver Diseases and Immunity
article

Random blood glucose and subsequent autoimmune hepatitis in the UK Biobank cohort

Tingfei Yan, Xiaobei Han, Xuedi Cheng, Junzheng Wang, Aiping Chen, Yanan Duan
article en

Abstract

Background The association between baseline random blood glucose (RBG) and subsequent autoimmune hepatitis (AIH), and its relationship with systemic inflammation, remain unclear. Method The original UK Biobank analysis included 425,489 participants with 284 AIH records. After exclusion of two participants with AIH recorded on or before baseline, the prospective analyses included 425,487 participants and 282 incident hospital-recorded AIH events. A small hospital-based case-control sample from the Affiliated Hospital of Qingdao University, comprising 23 AIH cases and nine controls, provided supplementary descriptive information and exploratory analyses and was not used for external validation. Logistic regression, Cox regression, and two-year landmark analyses were used to examine the associations with AIH. Restricted cubic spline, exploratory threshold, subgroup, ROC, and mediation analyses were also performed. The jointly adjusted Cox model included age, sex, ethnicity, Townsend deprivation index, educational attainment, smoking status, and alcohol consumption. Result In the jointly adjusted baseline Cox model, each 1 mmol/L higher RBG was associated with an HR of 1.096 (95% CI, 1.023-1.176; P = 0.0095), whereas the highest-versus-lowest quartile comparison was not statistically significant (HR, 1.315; 95% CI, 0.945-1.831; P = 0.1046). In the two-year landmark analysis, the corresponding HRs were 1.115 (95% CI, 1.042-1.193; P = 0.0016) and 1.549 (95% CI, 1.080-2.222; P = 0.0175). RBG alone showed limited discrimination (AUC, 0.531; 95% CI, 0.496-0.566). Conclusion Higher baseline RBG was modestly associated with subsequent hospital-recorded AIH, although quartile comparisons differed between baseline and landmark analyses. These exploratory findings do not establish causality or a clinically actionable glucose threshold. The limited discrimination of RBG does not support its use as a standalone screening marker for AIH.

Frontiers in ImmunologyVol. 17
Affiliated Hospital of Qingdao University (CN), Haier Group (China) (CN), Qingdao Haici Medical Group (CN)
Good health and well-being
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon